An interventional study of Health Promotion Behavior Education in Caregiver Burden, Quality of Life and Public Health, sponsored by Aydin Adnan Menderes University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by Aydin Adnan Menderes University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This randomized controlled trial will be conducted to examine the effect of a multidimensional training program, to be implemented by a public health nurse, on the care burden and quality of life of primary caregivers of patients aged 65 and older.
503 studies on the registry are indexed under Caregiver Burden; 166 are open to participants now.
This study's planned enrollment of 78 is close to the median of 73 across 404 interventional studies indexed under Caregiver Burden.
Browse Caregiver Burden studies →Aydin Adnan Menderes University is the lead sponsor of 243 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Be willing to participate in the study
Exclusion Criteria:
Having severe reading comprehension difficulties
The control group continued to receive the routine care
Caregivers in the intervention groups will undergo a four-session intervention program in addition to the routine care provided by other caregivers. The training, which is planned to last four weeks and includes activities aimed at reducing the impact of the caregiving role on caregivers, involves the delivery of a training program designed to improve caregivers' adaptation to their caregiving roles.
Behavioral: Health Promotion Behavior Education
Personal hygiene, hand hygiene, Musculoskeletal system, body mechanics, relaxation exercises, the importance of physical activity, Proper and healthy nutrition, foods to increase and decrease consumption of, food safety and hygiene, Sleep health, sleep hygiene, the importance of sleep in human life, sleep quality, sleep duration, and factors affecting sleep, Early detection methods, adult immunization, rational use of medications, Safe environment and home accidents.
Also known as: Social health dimension, Physical health, Psychological health dimension, Emotional health dimension
Before intervention caregiving burden
The Caregiver Burden Scale will be used to assess the stress experienced by caregivers. It consists of 22 statements that evaluate the impact of caregiving on the caregiver's life and uses a Likert-type scale. The scale's highest score is 88, and the lowest is 0. Higher scores are associated with an increased caregiving burden.
Time frame: Before intervention
After intervention caregiving burden
The Caregiver Burden Scale will be used to assess the stress experienced by caregivers. It consists of 22 statements that assess the impact of caregiving on the caregiver's life and uses a Likert-type scale. The maximum score on the scale is 88, and the minimum is 0. Higher scores are associated with increased caregiving burden.
Time frame: 1 week after intervention
Before intervention
Pre-Intervention Life Satisfaction This scale was developed to assess how an individual perceives their quality of life. The scale was created by condensing the World Health Organization Quality of Life Assessment scale to 26 questions. During the validity studies of the Turkish version, a national question was added, bringing the total number of questions to 27, and the Turkish version was finalized. Comprising closed-ended questions, the scale consists of the following subdimensions: general health, physical, social, environmental, and psychological. The minimum score that can be obtained from the scale is 0, and the maximum score is 100. An increase in the score indicates an improvement in quality of life.
Time frame: Before intervention
After intervention
Post-Intervention Life Satisfaction This scale was developed to assess how an individual perceives their quality of life. The scale was created by condensing the World Health Organization Quality of Life Assessment scale to 26 questions. During the validity studies of the Turkish version, a national question was added, bringing the total number of questions to 27, and the Turkish version was finalized. Comprising closed-ended questions, the scale consists of the following subdimensions: general health, physical, social, environmental, and psychological. The minimum score that can be obtained from the scale is 0, and the maximum score is 100. An increase in the score indicates an improvement in quality of life.
Time frame: 1 week after intervention
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Feb 2027, 2 months later.
Of 285 non-industry interventional studies with no phase under Caregiver Burden, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's planned 2 months is below that.
Counting every sponsor, half of 294 studies reached it within 16 months; a quarter within 7 and three quarters within 31.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 2, 2026: start Jul 2026 → Dec 2026, primary completion Aug 2026 → Feb 2027 and completion Aug 2026 → Mar 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aydin Adnan Menderes University →